| PERIOD ENDING | 26-Sep-09 | 27-Jun-09 | 28-Mar-09 | 27-Dec-08 | | Total Revenue | 44,062 | 38,424 | 36,582 | 41,401 | | Cost of Revenue | 27,845 | 26,096 | 29,187 | 33,238 | | | Gross Profit | 16,217 | 12,328 | 7,395 | 8,163 | | | Operating Expenses | | Research Development | 8,284 | 7,773 | 7,965 | 8,502 | | Selling General and Administrative | 8,731 | 8,655 | 9,045 | 8,960 | | Non Recurring |
-
|
-
|
-
| 2,577 | | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (798) | (4,100) | (9,615) | (11,876) | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
| 343 | 483 | 1,201 | | Earnings Before Interest And Taxes | (496) | (3,757) | (9,132) | (10,675) | | Interest Expense |
-
|
-
|
-
|
-
| | Income Before Tax | (496) | (3,757) | (9,132) | (10,675) | | Income Tax Expense | (425) | 18,848 | (2,870) | (3,069) | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (71) | (22,605) | (6,262) | (7,606) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (71) | (22,605) | (6,262) | (7,606) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($71) | ($22,605) | ($6,262) | ($7,606) |
|
0.22% Nasdaq 0.00%
Income Statement
